Magenta

EQS-News: Heidelberg Pharma announces financial figures and reports on successful business performance in 2023

Retrieved on: 
Wednesday, April 10, 2024
Malignancy, Spanish mythology, State university system, Patient, Sale, Renal cell carcinoma, Clinical trial, Neoplasm, Therapy, Depreciation, HPHA, USD, Marketing, GLP, Health, Research, ATACS, EPO, Immune system, ADC, BLA, ATAC, Food, Biologics license application, Disease, Magenta, Multiple myeloma, AACR, GCC, Annual report, FDA, Diagnosis, EUR, Supervisory board, Accounting, PET, EDT, Spacecraft, Amanitin, European Patent Convention, Patent, Eli Lilly and Company, Binghamton University, Pharmaceutical industry

Minority interest in Emergence sold: In summer 2023, Heidelberg Pharma sold its minority interest in Emergence Therapeutics AG, Duisburg, Germany, (Emergence).

Key Points: 
  • Minority interest in Emergence sold: In summer 2023, Heidelberg Pharma sold its minority interest in Emergence Therapeutics AG, Duisburg, Germany, (Emergence).
  • As a result, Heidelberg Pharma lost sales revenue in the low single-digit millions for the 2023 financial year.
  • In April 2023, Heidelberg Pharma signed a termination agreement with Magenta under which all licensed ATAC rights and some Magenta patents were assumed by Heidelberg Pharma.
  • The Heidelberg Pharma Group includes two entities, Heidelberg Pharma AG and Heidelberg Pharma Research GmbH.

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results

Retrieved on: 
Thursday, March 21, 2024
Janus, Research, MMN, Myasthenia gravis, Dianthus, GMG, CIDP, Half-life, Form, Patient, Complement component 1s, Magenta, Acetylcholine, American Academy, CMC, G&A, YTE, Drug, AAN, Investment, Therapy, PIPE, Magic, Multifocal motor neuropathy, Annual general meeting, Pharmaceutical industry

NEW YORK and WALTHAM, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today reported financial results for the fourth quarter and full year ending December 31, 2023, and provided an update on recent business achievements.

Key Points: 
  • DNTH103 has the potential to be a best-in-class pipeline-in-a-product across a range of autoimmune disorders with high unmet need.
  • Initial top-line results from this trial are anticipated to be available in the second half of 2025.
  • Dianthus successfully completed a private investment in public equity (“PIPE”) financing in January 2024 that resulted in gross proceeds of approximately $230 million.
  • Additional Information – For additional information on the Company’s financial results for the year ended December 31, 2023, please refer to the Form 10-K filed with the SEC.

T-Mobile Customers Now Have “Magenta Status” — VIP Vibes with One-of-a-Kind Benefits Across Premium Brands and Services

Retrieved on: 
Wednesday, February 7, 2024
Women, Technology, Men, Hispanic, Family, Events, Concerts, Apps, Applications, TV and Radio, Mobile, Wireless, Consumer, Film & Motion Pictures, 5G, Other Travel, Carriers and Services, Lodging, Destinations, Travel, Entertainment, Telecommunications, Networks, Internet, Electric vehicle, Multimedia, JUST, Magenta, TMUS, IOS, T-Mobile, Android, VIP, Netflix, Dollar, Apple TV, Shell, Head, Tax, Verizon Communications, Hulu, EV, Live Nation Entertainment, Love, Cough, Curio (brand), Parmesan, Airport, ALL, Hilton Worldwide, AT&T, Formula, Little Caesars, Sport, UN

Magenta Status gives T-Mobile customers VIP vibes with an exclusive suite of benefits with the brands they love — JUST for being customers.

Key Points: 
  • Magenta Status gives T-Mobile customers VIP vibes with an exclusive suite of benefits with the brands they love — JUST for being customers.
  • With Magenta Status, customers can get 15% off across Hilton’s 22 leading hotel brands worldwide, from Hampton to Curio Collection by Hilton, Waldorf Astoria and more.
  • Silver benefits include things like free Wi-Fi, a fifth night free on reward stays, all-inclusive spa discount and more.
  • New Benefits, New App: Introducing T Life, a brand-new app to make it easy for T-Mobile customers to keep track of their perks, VIP benefits, T-Mobile Tuesdays and more.

T-Mobile Customers Unlock Faster Speeds and Major Value with the New Samsung Galaxy S24 Series

Retrieved on: 
Wednesday, January 17, 2024
Technology, 5G, Carriers and Services, Telecommunications, Hispanic, Networks, Internet, Consumer, Consumer Electronics, Payment card, UN, TB, Samsung Galaxy S23, T-Mobile, A15, Samsung, Sale, Samsung Galaxy Tab series, FRP, MLB.TV, Samsung Galaxy, Mah, Blue Black, Galaxy, Smartphone, Data-rate units, TMUS, Magenta, Apple TV, Equipment, Business, AI, Netflix, Mastercard, Microsoft Office, Human, IOS, Secure, Hertz, Multimedia, S24, Microsoft, Android, Travel, Tablet, UL, Mobile phone

With the Samsung Galaxy S24 series being the first to leverage uplink carrier aggregation, T-Mobile customers can get up to 90% faster uplink speeds than the previous Samsung lineup, making things like video uploads nearly twice as fast.

Key Points: 
  • With the Samsung Galaxy S24 series being the first to leverage uplink carrier aggregation, T-Mobile customers can get up to 90% faster uplink speeds than the previous Samsung lineup, making things like video uploads nearly twice as fast.
  • Samsung Galaxy S24 Ultra for $99 (or $1200 off) with adding a line and porting on Business Unlimited Ultimate.
  • Double the storage on any of the new Samsung devices, during pre-order only, meaning get the 512GB Samsung Galaxy S24+ or Samsung Galaxy S24 Ultra phone for the price of the 256GB.
  • Samsung Galaxy S24 has an updated 6.2” FHD+ Flat display and more juice thanks to its new, larger 4000mAh battery.

EQS-News: cyan AG sells BSS/OSS segment and focuses on high-growth business with intelligent cybersecurity solutions

Retrieved on: 
Saturday, December 30, 2023
AG, Partnership, Classification, Steam, BSS, Sale, Telecommunications, Acquisition, Claro, Investment, DTAC, Big data, Cloud computing, MVNO, Machine learning, Growth, Magenta, Intelligence, Cyan

Munich, December 19, 2023 – cyan AG, a European provider of IT security solutions, is selling its BSS/OSS segment for MVNO software.

Key Points: 
  • Munich, December 19, 2023 – cyan AG, a European provider of IT security solutions, is selling its BSS/OSS segment for MVNO software.
  • Markus Cserna, Interim-CEO und CTO of cyan AG: "With the sale of our BSS/OSS segment, we are focusing on our core business.
  • cyan is thus strengthening the development of first-class security solutions that effectively address the increasing challenges of the digital world.
  • By concentrating on its core business, cyan is streamlining its organization, becoming more agile and optimizing its cost structure.

Dianthus Therapeutics Highlights Recent Business Achievements and Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 9, 2023
MMN, Muscle contraction, Therapy, Multifocal motor neuropathy, Investment, Disease, Risk, Form, Magenta, GMG, Patient, Complement component 1s, Research, CIDP, Bacteria, Half-life, Infection, Dianthus, YTE, Vaccine, Pharmaceutical industry, Airline, Cryptocurrency

Top-line Phase 1 data across seven single and multiple ascending dose cohorts with 52 healthy volunteers establish DNTH103’s best-in-class potential.

Key Points: 
  • Top-line Phase 1 data across seven single and multiple ascending dose cohorts with 52 healthy volunteers establish DNTH103’s best-in-class potential.
  • Research and development expenses for the quarter ended September 30, 2023 were $8.0 million, inclusive of $0.4 million of stock-based compensation.
  • Net loss for the quarter ended September 30, 2023 was $14.8 million or $3.78 net loss per share (basic and diluted).
  • For additional information on the Company’s financial results for the quarter ended September 30, 2023, please refer to the Form 10-Q filed with the SEC.

GESKE German Beauty Tech Announces Global Brand Launch

Retrieved on: 
Thursday, December 14, 2023
Midnight, New product development, Engineering, Oil lamp, Amazon, App Store (iOS/iPadOS), Imagination, Collection, Magenta, Puffy, LED, Starlight, Massage, Urban Outfitters, Pink, AI, Skin, Pulsation reactor, Beauty salon, Cosmetics, Green

BERLIN, Dec. 14, 2023 /PRNewswire/ -- GESKE German Beauty Tech, a new global brand that merges German engineering, proven skincare expertise and AI technology, makes its worldwide debut with the launch of the first holistic SmartAppGuided™ skincare range, featuring 250 clinically tested and innovative skincare devices. By harnessing the power of AI, GESKE German Beauty Tech is helping users curate personalized skincare routines tailored to their skin's needs through its tech-centric beauty devices paired with the free AI-powered app. All GESKE German Beauty Tech devices have been awarded the Dermatest seal of approval, which is the most authoritative scientific label for independently tested products that come into contact with the skin.

Key Points: 
  • With over 250 products available in 131 countries, GESKE German Beauty Tech offers cutting edge beauty devices under $100
    BERLIN, Dec. 14, 2023 /PRNewswire/ -- GESKE German Beauty Tech , a new global brand that merges German engineering, proven skincare expertise and AI technology, makes its worldwide debut with the launch of the first holistic SmartAppGuided™ skincare range, featuring 250 clinically tested and innovative skincare devices.
  • By harnessing the power of AI, GESKE German Beauty Tech is helping users curate personalized skincare routines tailored to their skin's needs through its tech-centric beauty devices paired with the free AI-powered app .
  • GESKE German Beauty Tech devices are for anyone over the age of 14 looking to upgrade their at-home skincare routine.
  • The GESKE German Beauty Tech app has been awarded with the CES Innovation Award 2023 as well as the prestigious German Innovation Award 2023, recognizing its ability to enhance and democratize beauty technology for all beauty consumers, through personalized SmartAppGuided™ skincare.

Bill Hoffman Joins Magenta Medical's Board of Directors

Retrieved on: 
Tuesday, November 21, 2023
Medtronic, EV3, Magenta, Medtech, IPO

KADIMA, Israel, Nov. 21, 2023 /PRNewswire/ -- William (Bill) Hoffman has joined Magenta Medical's Board of Directors as an independent industry expert.

Key Points: 
  • KADIMA, Israel, Nov. 21, 2023 /PRNewswire/ -- William (Bill) Hoffman has joined Magenta Medical's Board of Directors as an independent industry expert.
  • Magenta Medical is developing the Elevate™ System, the smallest heart pump in the world.
  • Mr. Hoffman currently serves as a member of the board of directors of Inari Medical, where he was CEO from 2015 until 2022.
  • "Bill Hoffman is a widely respected and accomplished leader in the MedTech industry.

Holiday Shopping Done Early. Samsung and Motorola Devices Land at the Un-carrier for FREE

Retrieved on: 
Tuesday, October 10, 2023
Technology, Mobile, Wireless, Carriers and Services, Consumer Electronics, Samsung Galaxy S9, ID, Multimedia, Microsoft, Motorola Razr, Business, Motorola Moto, Smartphone, Travel, Charge density, Metro, FREE, Netflix, Love, Samsung, T-Mobile, Magenta, Motorola, TMUS, Apple TV, Sale, News, Metal Max 4: Gekkō no Diva, UN, Secure, Wi-Fi, Samsung Galaxy S6, Mobile phone, Video game, Carrier

Today, T-Mobile (NASDAQ: TMUS) announced that four new devices are coming to T-Mobile and Metro by T-Mobile this month: motorola razr, moto g power 5G, Samsung Galaxy S23 FE and Samsung Galaxy Tab S9 FE.

Key Points: 
  • Today, T-Mobile (NASDAQ: TMUS) announced that four new devices are coming to T-Mobile and Metro by T-Mobile this month: motorola razr, moto g power 5G, Samsung Galaxy S23 FE and Samsung Galaxy Tab S9 FE.
  • Samsung and Motorola Devices Land at the Un-carrier for FREE (Photo: Business Wire)
    motorola razr.
  • New and existing Metro customers can get it free when adding a new line on Metro’s most popular plan with ID verification.
  • Qualifying credit, service, and, for trade-in offer, trade-in (e.g., Save $800: Samsung Galaxy S9; Save $400: Samsung Galaxy S6) required.

Results from Magenta Medical's US Early Feasibility Study of the World's Smallest and Most Powerful Heart Pump to be Highlighted at TCT 2023

Retrieved on: 
Tuesday, October 10, 2023
Coronary artery disease, Mount Sinai Hospital (Manhattan), Percutaneous coronary intervention, Safety, Hospital, Teaching hospital, Diagnosis, Cardiology, Mount Sinai Hospital, Magenta, Ventricular assist device, Interventional cardiology, Philippine Heart Center, North Shore University Hospital, St. Francis Hospital, TCT, Patient, Pharmaceutical industry, Medical device

KADIMA, Israel , Oct. 10, 2023 /PRNewswire/ --Results from Magenta Medical's Early Feasibility Study of the Elevate™ System, for the high-risk percutaneous coronary intervention (HR-PCI) indication, will be announced in an oral presentation at the Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of the Cardiovascular Research Foundation in San Francisco. Elevate™ is the world's smallest and most powerful percutaneous Left Ventricular Assist Device (pLVAD).

Key Points: 
  • Elevate™ is the world's smallest and most powerful percutaneous Left Ventricular Assist Device (pLVAD).
  • Presentation title: Magenta Elevate™: First US Experience with High-Output, Low-French Size Percutaneous Mechanical Circulatory Support
    Session: TCT Innovation V: Innovation in Coronary Disease Diagnosis and Therapies/Featured Technological Trends: Percutaneous Mechanical Circulatory Support.
  • Magenta's US Early Feasibility Study was initiated to evaluate the safety and feasibility of the Elevate™ System in providing temporary mechanical circulatory support during HR-PCI procedures.
  • Fifteen patients were treated in the study at the Mount Sinai Hospital, St. Francis Hospital and Heart Center, and North Shore University Hospital.